相似文献
1
Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.
Gut. 1974 Dec;15(12):960-5. doi: 10.1136/gut.15.12.960.
2
3
The microbial flora of the rectal mucosa and faeces of patients with Crohn's disease before and during antimicrobial chemotherapy.
J Med Microbiol. 1984 Dec;18(3):335-45. doi: 10.1099/00222615-18-3-335.
4
The faecal flora of patients with Crohn's disease.
J Hyg (Lond). 1981 Aug;87(1):1-12. doi: 10.1017/s0022172400069187.
5
The influence of a diet rich in wheat fibre on the human faecal flora.
J Med Microbiol. 1976 Nov;9(4):423-31. doi: 10.1099/00222615-9-4-423.
6
[Changes of fecal flora and its correlation with inflammatory indicators in patients with inflammatory bowel disease].
Nan Fang Yi Ke Da Xue Xue Bao. 2013 Oct;33(10):1474-7.
7
Drug management of inflammatory bowel disease.
Ir Med J. 1983 May;76(5):260-2.
8
Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine.
Gut. 1994 Oct;35(10):1385-8. doi: 10.1136/gut.35.10.1385.
9
Clinical effect of metronidazole and sulfasalazine on Crohn's disease in relation to changes in the fecal flora.
Scand J Gastroenterol. 1981;16(4):569-75. doi: 10.3109/00365528109182013.
10
Clostridium difficile and inflammatory bowel disease.
Gut. 1983 Aug;24(8):713-7. doi: 10.1136/gut.24.8.713.
引用本文的文献
1
Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease.
Front Microbiol. 2023 Feb 23;14:1107976. doi: 10.3389/fmicb.2023.1107976. eCollection 2023.
2
Gastrointestinal dysbiosis and Escherichia coli pathobionts in inflammatory bowel diseases.
APMIS. 2022 Aug;130 Suppl 144(Suppl 144):1-38. doi: 10.1111/apm.13256.
3
Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation.
Front Pharmacol. 2020 Nov 11;11:594042. doi: 10.3389/fphar.2020.594042. eCollection 2020.
4
The role of microbiome in rheumatoid arthritis treatment.
Ther Adv Musculoskelet Dis. 2019 Jul 30;11:1759720X19844632. doi: 10.1177/1759720X19844632. eCollection 2019.
5
Modulation of Gut Microbiome Composition and Function in Experimental Colitis Treated with Sulfasalazine.
Front Microbiol. 2017 Sep 7;8:1703. doi: 10.3389/fmicb.2017.01703. eCollection 2017.
6
Inflammatory bowel disease as a model for translating the microbiome.
Immunity. 2014 Jun 19;40(6):843-54. doi: 10.1016/j.immuni.2014.05.013.
7
Oral nanotherapeutics: effect of redox nanoparticle on microflora in mice with dextran sodium sulfate-induced colitis.
J Gastroenterol. 2014 May;49(5):806-13. doi: 10.1007/s00535-013-0836-8. Epub 2013 May 29.
8
Mesalamine suppresses the expression of TC22, a novel tropomyosin isoform associated with colonic neoplasia.
Mol Pharmacol. 2009 Jul;76(1):183-91. doi: 10.1124/mol.109.056028. Epub 2009 Apr 15.
9
Escherichia coli and ulcerative colitis.
J R Soc Med. 1997 Nov;90(11):612-7. doi: 10.1177/014107689709001106.
10
The effect of intestinal bacteria adherence on drug diffusion through solid films under stationary conditions.
Pharm Res. 1997 Apr;14(4):503-7. doi: 10.1023/a:1012159818727.
本文引用的文献
1
CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS.
Gut. 1964 Oct;5(5):437-42. doi: 10.1136/gut.5.5.437.
2
Distribution and metabolism of salicyl-azo-sulfapyridine. I. A study with C-14-5-amino-salicylic acid.
Acta Med Scand. 1963 Jan;173:61-72. doi: 10.1111/j.0954-6820.1963.tb16506.x.
3
Sulphasalazine and salicylazosulphadimidine in ulcerative colitis.
Lancet. 1962 May 26;1(7239):1094-6. doi: 10.1016/s0140-6736(62)92080-9.
4
Bacteriologic aspects of ulcerative colitis.
Gastroenterology. 1961 Feb;40:323-30.
5
Transport and storage of faeces for bacteriological examination.
J Appl Bacteriol. 1971 Jun;34(2):477-83. doi: 10.1111/j.1365-2672.1971.tb02307.x.
6
Properties of strains of Escherichia coli isolated from the faeces of patients with ulcerative colitis, patients with acute diarrhoea and normal persons.
J Pathol Bacteriol. 1968 Jan;95(1):101-13. doi: 10.1002/path.1700950112.
7
Cultivation of anaerobic intestinal bacteria.
J Pathol Bacteriol. 1967 Oct;94(2):417-27. doi: 10.1002/path.1700940223.
8
Properties of strains of Escherichia coli carried in different phases of ulcerative colitis.
Gut. 1974 Feb;15(2):143-6. doi: 10.1136/gut.15.2.143.
9
Absorption, metabolism, and excretion of salicylazosulfapyridine in man.
Clin Pharmacol Ther. 1972 Jul-Aug;13(4):539-51. doi: 10.1002/cpt1972134539.
10
The role of intestinal bacteria in the metabolism of salicylazosulfapyridine.
J Pharmacol Exp Ther. 1972 Jun;181(3):555-62.
Zotero 插件